Regulatory Affairs

Mobile Health on the Rise: Exploring the Regulatory Landscape for Reimbursement

For DTx solutions to be integrated into mainstream healthcare, they must secure health authority (HA) approval. In certain scenarios, if the solution offers considerable societal benefits, HAs might even permit DTx to be prescribed by healthcare professionals and, depending on the country, offer reimbursement.

This whitepaper will help you navigate the intricate maze of the current DTx regulatory environment, highlighting several important countries and regulations.

Whitepaper IPAD - Mobile Health On The Rise

Download now

Come visit our booth at CPHI Barcelona 2023

Come to see the QbD Group at stand #3G73 at CPHI Conference in Barcelona. And after the conference…Eat & Connect with lifescience professionals at our QbD’s CPHI Networking Drink.